Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOSUNETUZUMAB-AXGB vs MULTIHANCE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOSUNETUZUMAB-AXGB vs MULTIHANCE: Safety Overview

Metric MOSUNETUZUMAB-AXGB MULTIHANCE
Total FAERS Reports 198 183
Deaths Reported 13 14
Death Rate 6.6% 7.7%
Hospitalizations 48 33
Average Patient Age 63.5 yrs 52.0 yrs
% Female Patients 56.1% N/A
Marketing Status Prescription N/A